A Phase Ib Study of IMU-131 HER2/neu peptide vaccine plus chemotherapy in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction

被引：0

作者：

Chao, Y. ^{[1
]}

Maglakelidze, M. ^{[2
]}

Bulat, L. V. ^{[3
]}

Yau, T. ^{[4
]}

Tanasanvimon, S. ^{[5
]}

Charoentum, C. ^{[6
]}

Arpornwirat, W. ^{[7
]}

Maneechavakajorn, J. ^{[8
]}

Dechaphunkul, A. ^{[9
]}

Ungtrakul, T. ^{[10
]}

Yen, C-J. ^{[11
]}

Bai, L-Y. ^{[12
]}

Chou, W-C. ^{[13
]}

Weidermann, U. ^{[14
]}

Garner-Spitzer, E. ^{[15
]}

Ede, N. ^{[16
]}

Chong, L. ^{[17
]}

Good, A. ^{[17
]}

机构：

[1] Taipei Vet Gen Hosp, Oncol, Taipei, Taiwan

[2] ARENSIA, Exploratory Med, Tbilisi, Georgia

[3] Inst Oncol Chisinau, Med Oncol, Kishinev, Moldova

[4] Queen Mary Hosp, Dept Med, Hong Kong, Peoples R China

[5] Chulalongkorn Univ, Fac Med, Internal Med, Pathumwan, Thailand

[6] Maharaj Nakorn Chiang Mai Hosp, Oncol, Chiang Mai, Thailand

[7] Natl Canc Inst, Oncol, Bangkok, Thailand

[8] Rajavithi Hosp, Oncol, Pathumwan, Thailand

[9] Songklanagarind Hosp, Oncol, Hat Yai, Thailand

[10] Chulabhorn Hosp, Med, Bangkok, Thailand

[11] Natl Cheng Kung Univ Hosp, Oncol, Tainan, Taiwan

[12] China Med Univ Hosp, Oncol, Taichung, Taiwan

[13] Linkou Chang Gung Mem Hosp, Oncol, Taoyuan, Taiwan

[14] Med Univ Vienna, Immunol, Vienna, Austria

[15] MedUni Wien, Inst Specif Prophylaxis & Trop Med, Vienna, Austria

[16] Imugene, Preclin, Sydney, NSW, Australia

[17] Imugene, Clin, Sydney, NSW, Australia

来源：

ANNALS OF ONCOLOGY | 2019年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

150P

引用

页数：1